Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scholl, T. O.
Right arrow Articles by Reilly, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scholl, T. O.
Right arrow Articles by Reilly, T.
(Journal of Nutrition. 2000;130:443S-447S.)
© 2000 The American Society for Nutritional Sciences


Supplement

Anemia, Iron and Pregnancy Outcome1 ,2

Theresa O. Scholl3 and Thomas Reilly*

Department of Obstetrics and Gynecology, University of Medicine and Dentistry of New Jersey-SOM and * Department of Primary Care, University of Medicine and Dentistry of New Jersey-SHRP, Stratford, NJ 08084

3To whom correspondence should be addressed.

When maternal anemia is diagnosed before midpregnancy, it has been associated with an increased risk of preterm delivery. Maternal anemia detected during the later stages of pregnancy, especially the third trimester, often reflects the expected (and necessary) expansion of maternal plasma volume. Third-trimester anemia usually is not associated with increased risk of preterm delivery. High hemoglobin concentration, elevated hematocrit and increased levels of serum ferritin late in pregnancy, however, all have been associated with increased preterm delivery. This increased risk may reflect in part the failure to expand maternal plasma volume adequately, thus diminishing appropriate placental perfusion. Although controlled trials of iron supplementation during pregnancy have consistently demonstrated positive effects on maternal iron status at delivery, they have not demonstrated reductions in factors that are associated with maternal anemia, i.e., increased risk of preterm delivery and infant low birth weight. One reason for discordant findings may be the exclusion of many gravidas with iron deficiency from these trials or the data concerning gravidas with pregnancy outcomes such as preterm delivery from the analysis. Finally, recent concerns have been voiced about harmful effects of iron supplementation during pregnancy. No adverse effects of iron supplementation on pregnancy outcome have been demonstrated to date. Questions about the efficacy of iron supplementation during pregnancy for reducing adverse outcomes such as preterm delivery and side effects from iron supplementation, including the potential for oxidation of lipids and DNA, require further research in iron-deficient women.


KEY WORDS: • iron • anemia • hemoglobin • ferritin • pregnancy outcome




This article has been cited by other articles:


Home page
BMJHome page
L. Zeng, Y. Cheng, S. Dang, H. Yan, M. J Dibley, S. Chang, and L. Kong
Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial
BMJ, November 7, 2008; 337(nov07_4): a2001 - a2001.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
R. LAROCQUE, M. CASAPIA, E. GOTUZZO, and T. W. GYORKOS
RELATIONSHIP BETWEEN INTENSITY OF SOIL-TRANSMITTED HELMINTH INFECTIONS AND ANEMIA DURING PREGNANCY
Am J Trop Med Hyg, October 1, 2005; 73(4): 783 - 789.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Randerath, G.-D. Zhou, R. L. Somers, J. H. Robbins, and P. J. Brooks
A 32P-Postlabeling Assay for the Oxidative DNA Lesion 8,5'-Cyclo-2'-deoxyadenosine in Mammalian Tissues. EVIDENCE THAT FOUR TYPE II I-COMPOUNDS ARE DINUCLEOTIDES CONTAINING THE LESION IN THE 3' NUCLEOTIDE
J. Biol. Chem., September 14, 2001; 276(38): 36051 - 36057.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2000 by American Society for Nutrition